Functional Predictors Discriminating Asthma–COPD Overlap (ACO) from Chronic Obstructive Pulmonary Disease (COPD)

References

• Global Initiative for Chronic Obstructive Lung Disease. 2020 Global strategy for prevention, diagnosis and management of COPD; 2020. Available from: https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf). Accessed October 13, 2022.
   Google Scholar
• Agusti A, Vestbo J. Current controversies and future perspectives in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;184(5):507–513. doi:10.1164/rccm.201103-0405PP
   PubMed Web of Science ®Google Scholar
• Faner R, Agusti A. Multilevel, dynamic chronic obstructive pulmonary disease heterogeneity. A challenge for personalized medicine. Ann Am Thorac Soc. 2016;13(Suppl 2):S466–S470. doi:10.1513/AnnalsATS.201605-372AW
   PubMed Web of Science ®Google Scholar
• Han MK, Quibrera PM, Carretta EE, et al. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort. Lancet Respir Med. 2017;5(8):619–626. doi:10.1016/S2213-2600(17)30207-2
   PubMed Web of Science ®Google Scholar
• Agusti A, MacNee W. The COPD control panel: towards personalised medicine in COPD. Thorax. 2013;68(7):687–690. doi:10.1136/thoraxjnl-2012-202772
   PubMed Web of Science ®Google Scholar
• Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax. 2009;64(8):728–735. doi:10.1136/thx.2008.108027
   PubMed Web of Science ®Google Scholar
• Zeki AA, Schivo M, Chan A, Albertson TE, Louie S. The asthma-COPD overlap syndrome: a common clinical problem in the elderly. J Allergy. 2011;2011:861926. doi:10.1155/2011/861926
   PubMedGoogle Scholar
• Kauppi P, Kupiainen H, Lindqvist A, et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma. 2011;48(3):279–285. doi:10.3109/02770903.2011.555576
   PubMed Web of Science ®Google Scholar
• Diaz-Guzman E, Khosravi M, Mannino DM. Asthma, chronic obstructive pulmonary disease, and mortality in the U.S. population. Copd. 2011;8(6):400–407. doi:10.3109/15412555.2011.611200
   PubMedGoogle Scholar
• Louie S, Zeki AA, Schivo M, et al. The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations. Expert Rev Clin Pharmacol. 2013;6(2):197–219. doi:10.1586/ecp.13.2
   PubMed Web of Science ®Google Scholar
• de Marco R, Pesce G, Marcon A, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population. PLoS One. 2013;8(5):e62985. doi:10.1371/journal.pone.0062985
   PubMed Web of Science ®Google Scholar
• Milanese M, Di Marco F, Corsico AG, et al. Asthma control in elderly asthmatics. An Italian observational study. Respir Med. 2014;108(8):1091–1099. doi:10.1016/j.rmed.2014.05.016
   PubMed Web of Science ®Google Scholar
• Postma DS, Rabe KF. The asthma-COPD overlap syndrome. N Engl J Med. 2015;373(13):1241–1249. doi:10.1056/NEJMra1411863
   PubMed Web of Science ®Google Scholar
• Woodruff PG, van den Berge M, Boucher RC, et al. American thoracic society/national heart, lung, and blood institute asthma-chronic obstructive pulmonary disease overlap workshop report. Am J Respir Crit Care Med. 2017;196(3):375–381. doi:10.1164/rccm.201705-0973WS
   PubMed Web of Science ®Google Scholar
• Mekov E, Nunez A, Sin DD, et al. Update on asthma-COPD overlap (ACO): a narrative review. Int J Chron Obstruct Pulmon Dis. 2021;16:1783–1799. doi:10.2147/COPD.S312560
   PubMed Web of Science ®Google Scholar
• Kraemer R, Smith HJ, Gardin F, et al. Bronchodilator response in patients with COPD, asthma-COPD-overlap (ACO) and asthma, evaluated by plethysmographic and spirometric z-score target parameters. Int J Chron Obstruct Pulmon Dis. 2021;16:2487–2500. doi:10.2147/COPD.S319220
   PubMed Web of Science ®Google Scholar
• Sin DD, Miravitlles M, Mannino DM, et al. What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion. Eur Respir J. 2016;48(3):664–673. doi:10.1183/13993003.00436-2016
   PubMed Web of Science ®Google Scholar
• Cosio BG, Soriano JB, Lopez-Campos JL, et al. Defining the asthma-COPD overlap syndrome in a COPD cohort. Chest. 2016;149(1):45–52. doi:10.1378/chest.15-1055
   PubMed Web of Science ®Google Scholar
• Suzuki M, Makita H, Konno S, et al. Asthma-like features and clinical course of chronic obstructive pulmonary disease. an analysis from the Hokkaido COPD cohort study. Am J Respir Crit Care Med. 2016;194(11):1358–1365. doi:10.1164/rccm.201602-0353OC
   PubMed Web of Science ®Google Scholar
• de Marco R, Marcon A, Rossi A, et al. Asthma, COPD and overlap syndrome: a longitudinal study in young European adults. Eur Respir J. 2015;46(3):671–679. doi:10.1183/09031936.00008615
   PubMed Web of Science ®Google Scholar
• Soler-Cataluna JJ, Cosio B, Izquierdo JL, et al. Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol. 2012;48(9):331–337. doi:10.1016/j.arbres.2011.12.009
   PubMed Web of Science ®Google Scholar
• Koblizek V, Chlumsky J, Zindr V, et al. Chronic Obstructive Pulmonary Disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013;157(2):189–201. doi:10.5507/bp.2013.039
   PubMed Web of Science ®Google Scholar
• Roman-Rodriguez M, Kaplan A. GOLD 2021 strategy report: implications for asthma-COPD overlap. Int J Chron Obstruct Pulmon Dis. 2021;16:1709–1715. doi:10.2147/COPD.S300902
   PubMed Web of Science ®Google Scholar
• Rogliani P, Ora J, Puxeddu E, Cazzola M. Airflow obstruction: is it asthma or is it COPD? Int J Chron Obstruct Pulmon Dis. 2016;11:3007–3013. doi:10.2147/COPD.S54927
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Alvarez-Gutierrez FJ, Calle M, et al. Algorithm for identification of asthma-COPD overlap: consensus between the Spanish COPD and asthma guidelines. Eur Respir J. 2017;49(5):1700068. doi:10.1183/13993003.00068-2017
   PubMed Web of Science ®Google Scholar
• Cukic V, Lovre V, Dragisic D, Ustamujic A. Asthma and chronic obstructive pulmonary disease (COPD) - differences and similarities. Mater Sociomed. 2012;24(2):100–105. doi:10.5455/msm.2012.24.100-105
   PubMedGoogle Scholar
• Miravitlles M, Andreu I, Romero Y, Sitjar S, Altes A, Anton E. Difficulties in differential diagnosis of COPD and asthma in primary care. Br J Gen Pract. 2012;62(595):e68–e75. doi:10.3399/bjgp12X625111
   PubMed Web of Science ®Google Scholar
• Stolz D, Barandun J, Borer H, et al. Diagnosis, prevention and treatment of stable COPD and acute exacerbations of COPD: the Swiss recommendations 2018. Respiration. 2018;96(4):382–398. doi:10.1159/000490551
   PubMed Web of Science ®Google Scholar
• Stocks J, Godfrey S, Beardsmore C, Bar-Yishay E, Castile R. Plethysmographic measurements of lung volume and airway resistance. ERS/ATS task force on standards for infant respiratory function testing. European Respiratory Society/ American Thoracic Society. Eur Respir J. 2001;17(2):302–312. doi:10.1183/09031936.01.17203020
   PubMed Web of Science ®Google Scholar
• Goldman M, Smith HJ, Ulmer WT. Lung function testing: whole-body plethysmography. Eur Respir Mon. 2005;31:15–43.
   Google Scholar
• Crieé CP, Sorichter S, Smith HJ, et al. Body plethysmography–its principles and clinical use. Respir Med. 2011;105(7):959–971. doi:10.1016/j.rmed.2011.02.006
   PubMed Web of Science ®Google Scholar
• Kraemer R, Blum A, Schibler A, Ammann RA, Gallati S. Ventilation inhomogeneities in relation to standard lung function in patients with cystic fibrosis. Am J Respir Crit Care Med. 2005;171(4):371–378. doi:10.1164/rccm.200407-948OC
   PubMed Web of Science ®Google Scholar
• Kraemer R, Delosea N, Ballinari P, Gallati S, Crameri R. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis. Am J Respir Crit Care Med. 2006;174(11):1211–1220. doi:10.1164/rccm.200603-423OC
   PubMed Web of Science ®Google Scholar
• Kraemer R, Smith HJ, Matthys H. Normative reference equations of airway dynamics assessed by whole-body plethysmography during spontaneous breathing evaluated in infants, children, and adults. Physiol Rep. 2021;9(17):e15027. doi:10.14814/phy2.15027
   PubMed Web of Science ®Google Scholar
• Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Consensus Development Conference. Am J Respir Crit Care Med. 2001;163(5):1256–1276. doi:10.1164/ajrccm.163.5.2101039
   PubMedGoogle Scholar
• Swanney MP, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Multicenter Study. Thorax. 2008;63(12):1046–1051. doi:10.1136/thx.2008.098483
   PubMed Web of Science ®Google Scholar
• Quanjer PH, Enright PL, Miller MR, et al. The need to change the method for defining mild airway obstruction. Eur Respir J. 2011;37(3):720–722. doi:10.1183/09031936.00135110
   PubMed Web of Science ®Google Scholar
• Scholes S, Moody A, Mindell JS. Estimating population prevalence of potential airflow obstruction using different spirometric criteria: a pooled cross-sectional analysis of persons aged 40–95 years in England and Wales. BMJ Open. 2014;4(7):e005685. doi:10.1136/bmjopen-2014-005685
   PubMed Web of Science ®Google Scholar
• McDonald VM, Fingleton J, Agusti A, et al. Treatable traits: a new paradigm for 21st century management of chronic airway diseases: treatable Traits Down Under International Workshop report. Eur Respir J. 2019;53(5):1802058. doi:10.1183/13993003.02058-2018
   PubMed Web of Science ®Google Scholar
• Cardoso J, Ferreira AJ, Guimaraes M, Oliveira AS, Simao P, Sucena M. Treatable traits in COPD - A proposed approach. Int J Chron Obstruct Pulmon Dis. 2021;16:3167–3182. doi:10.2147/COPD.S330817
   PubMed Web of Science ®Google Scholar
• Kraemer R, Smith HJ, Sigrist T, Giger G, Keller R, Frey M. Diagnostic accuracy of methacholine challenge tests assessing airway hyperreactivity in asthmatic patients - a multifunctional approach. Respir Res. 2016;17(1):154. doi:10.1186/s12931-016-0470-0
   PubMed Web of Science ®Google Scholar
• Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Officiaö statement of the European Respiratory Society. Eur Respir J. 1993;16:5–40. doi:10.1183/09041950.005s1693
   Web of Science ®Google Scholar
• Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Practice Guideline. Eur Respir J. 2005;26(5):948–968. doi:10.1183/09031936.05.00035205
   PubMed Web of Science ®Google Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Eur Respir J. 2017;49(3):1700214. doi:10.1183/13993003.00214-2017
   PubMed Web of Science ®Google Scholar
• Cotes JE, Chinn DJ, Quanjer PH, Roca J, Yernault JC. Standardization of the measurement of transfer factor (diffusing capacity). Eur Respir J. 1993;6(Suppl 16):41–52. doi:10.1183/09041950.041s1693
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
   PubMed Web of Science ®Google Scholar
• Matthys H. The assessment of airways obstruction. Bull Physiopathol Respir. 1973;9(4):961–978.
   PubMedGoogle Scholar
• Kirkby J, Stanojevic S, Welsh L, et al. Reference equations for specific airway resistance in children: the Asthma UK initiative. Eur Respir J. 2010;36(3):622–629. doi:10.1183/09031936.00135909
   PubMed Web of Science ®Google Scholar
• Kapsali T, Permutt S, Laube B, Scichilone N, Togias A. Potent bronchoprotective effect of deep inspiration and its absence in asthma. J Appl Physiol. 2000;89(2):711–720. doi:10.1152/jappl.2000.89.2.711
   PubMed Web of Science ®Google Scholar
• Salome CM, Thorpe CW, Diba C, Brown NJ, Berend N, King GG. Airway re-narrowing following deep inspiration in asthmatic and nonasthmatic subjects. Eur Respir J. 2003;22(1):62–68. doi:10.1183/09031936.03.00117502
   PubMed Web of Science ®Google Scholar
• Slats AM, Janssen K, van Schadewijk A, et al. Bronchial inflammation and airway responses to deep inspiration in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;176(2):121–128. doi:10.1164/rccm.200612-1814OC
   PubMed Web of Science ®Google Scholar
• Nensa F, Kotschy-Lang N, Smith HJ, Marek W, Merget R. Assessment of airway hyperresponsiveness: comparison of spirometry and body plethysmography. Comparative Study. Adv Exp Med Biol. 2013;755:1–9. doi:10.1007/978-94-007-4546-9_1
   PubMed Web of Science ®Google Scholar
• Dubois AB, Botelho SY, Bedell GN, Marshall R, Comroe JH. A rapid plethysmographic method for measuring thoracic gas volume: a comparison with a nitrogen washout method for measuring functional residual capacity in normal subjects. J Clin Invest. 1956;35(3):322–326. doi:10.1172/JCI103281
   PubMed Web of Science ®Google Scholar
• Dubois AB, Botelho SY, Comroe JH. A new method for measuring airway resistance in man using a body plethysmograph: values in normal subjects and in patients with respiratory disease. J Clin Invest. 1956;35(3):327–335. doi:10.1172/JCI103282
   PubMed Web of Science ®Google Scholar
• Jaeger MJ, Otis AB. Measurement of airway resistance with a volume displacement body plethysmograph. J Appl Physiol. 1964;19:813–820. doi:10.1152/jappl.1964.19.4.813
   PubMed Web of Science ®Google Scholar
• Ulmer WT, Marek W, Rasche K. Strömungswiderstandskurven bei obstruktiven Atemwegserkrankungen. Acht Typen der Strömungswiderstandskurven unter Spontanatmung [Airway resistance curves in obstructive respiratory tract diseases. 8 types of airway resistance curves in spontaneous respiration]. Fortschr Med. 1988;106(33):663–664. German
   PubMedGoogle Scholar
• Matthys H, Orth U. Comparative measurements of airway resistance. Respiration. 1975;32(2):121–134. doi:10.1159/000193642
   PubMed Web of Science ®Google Scholar
• Kraemer R. Whole-body plethysmography in the clinical assessment of infants with bronchopulmonary diseases. Respiration. 1993;60(1):1–8. doi:10.1159/000196165
   PubMed Web of Science ®Google Scholar
• Kusenbach G, Pott H, Breuer A, et al. Evaluation of a commercial infant body plethysmography. Eur Respir J. 1998;11(5):1211–1213. doi:10.1183/09031936.98.11051211
   PubMed Web of Science ®Google Scholar
• Zaiss AW, Matthys H. A multiuser system for whole body plethysmographic measurements and interpretation. Lung. 1990;168:Suppl:1185–92. doi:10.1007/BF02718260
   Web of Science ®Google Scholar
• Agostoni E, Mead J. Statics of the respiratory system. In: Fenn WO, Rahn H, editors. Handbook of Physiology. Washington D.C: American Physiological Society; 1964:411–427.
   Google Scholar
• Mead J, Turner JM, Macklem PT, Little JB. Significance of the relationship between lung recoil and maximum expiratory flow. J Appl Physiol. 1967;22(1):95–108. doi:10.1152/jappl.1967.22.1.95
   PubMed Web of Science ®Google Scholar
• Duggan CJ, Castle WD, Berend N. Effects of continuous positive airway pressure breathing on lung volume and distensibility. J Appl Physiol. 1990;68(3):1121–1126. doi:10.1152/jappl.1990.68.3.1121
   PubMed Web of Science ®Google Scholar
• Cerfolio RJ, Bryant AS. Different diffusing capacity of the lung for carbon monoxide as predictors of respiratory morbidity. Ann Thorac Surg. 2009;88(2):405–410. doi:10.1016/j.athoracsur.2009.04.015
   PubMed Web of Science ®Google Scholar
• Kraemer R, Baldwin DN, Ammann RA, Frey U, Gallati S. Progression of pulmonary hyperinflation and trapped gas associated with genetic and environmental factors in children with cystic fibrosis. Respir Res. 2006;7:138. doi:10.1186/1465-9921-7-138
   PubMed Web of Science ®Google Scholar
• Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, Morkve O. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J. 2002;20(5):1117–1122. doi:10.1183/09031936.02.00023202
   PubMed Web of Science ®Google Scholar
• Celli BR, Halbert RJ, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. Eur Respir J. 2003;22(2):268–273. doi:10.1183/09031936.03.00075102
   PubMed Web of Science ®Google Scholar
• Hansen JE, Sun XG, Wasserman K. Spirometric criteria for airway obstruction: use percentage of FEV1/FVC ratio below the fifth percentile, not < 70%. Chest. 2007;131(2):349–355. doi:10.1378/chest.06-1349
   PubMed Web of Science ®Google Scholar
• Miller MR, Quanjer PH, Swanney MP, Ruppel G, Enright PL. Interpreting lung function data using 80% predicted and fixed thresholds misclassifies more than 20% of patients. Chest. 2011;139(1):52–59. doi:10.1378/chest.10-0189
   PubMed Web of Science ®Google Scholar
• Stocks J, Quanjer PH. Reference values for residual volume, functional residual capacity and total lung capacity. ATS workshop on lung volume measurements. official statement of the European respiratory society. Eur Respir J. 1995;8(3):492–506. doi:10.1183/09031936.95.08030492
   PubMed Web of Science ®Google Scholar
• Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179–187. doi:10.1164/ajrccm.159.1.9712108
   PubMed Web of Science ®Google Scholar
• Zapletal A, Samanek M, Paul T. Lung Function in Children and Adolescents. Karger; 1987.
   Google Scholar
• Quanjer PH, Stocks J, Polgar G, Wise M, Karlberg J, Borsboom G. Compilation of reference values for lung function measurements in children. Eur Respir J Suppl. 1989;4:184S–261S.
   PubMedGoogle Scholar
• Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–1343. doi:10.1183/09031936.00080312
   PubMed Web of Science ®Google Scholar
• Kraemer R, Meister B. Fast real-time moment-ratio analysis of multibreath nitrogen washout in children. J Appl Physiol. 1985;59(4):1137–1144. doi:10.1152/jappl.1985.59.4.1137
   PubMed Web of Science ®Google Scholar
• Lum S, Stocks J, Stanojevic S, et al. Age and height dependence of lung clearance index and functional residual capacity. Eur Respir J. 2013;41(6):1371–1377. doi:10.1183/09031936.00005512
   PubMed Web of Science ®Google Scholar
• Stanojevic S, Wade A, Stocks J, et al. Reference ranges for spirometry across all ages: a new approach. Am J Respir Crit Care Med. 2008;177(3):253–260. doi:10.1164/rccm.200708-1248OC
   PubMed Web of Science ®Google Scholar
• Cole TJ, Stanojevic S, Stocks J, Coates AL, Hankinson JL, Wade AM. Age- and size-related reference ranges: a case study of spirometry through childhood and adulthood. Stat Med. 2009;28(5):880–898. doi:10.1002/sim.3504
   PubMed Web of Science ®Google Scholar
• Doershuk CF, Fisher BJ, Matthews LW. Specific airway resistance from the perinatal period into adulthood. Alterations in childhood pulmonary disease. Am Rev Respir Dis. 1974;109(4):452–457. doi:10.1164/arrd.1974.109.4.452
   PubMed Web of Science ®Google Scholar
• Beardsmore CS, Godfrey S, Shani N, Maayan C, Bar-Yishay E. Airway resistance measurements throughout the respiratory cycle in infants. Respiration. 1986;49(2):81–93. doi:10.1159/000194864
   PubMed Web of Science ®Google Scholar
• Yammine S, Singer F, Gustafsson P, Latzin P. Impact of different breathing protocols on multiple-breath washout outcomes in children. J Cyst Fibrosis. 2014;13(2):190–197. doi:10.1016/j.jcf.2013.08.010
   PubMed Web of Science ®Google Scholar
• Lange P, Celli B, Agusti A. Lung-function trajectories and chronic obstructive pulmonary disease. N Engl J Med. 2015;373(16):1575. doi:10.1056/NEJMc1510089
   PubMed Web of Science ®Google Scholar
• Agusti A, Faner R. Lung function trajectories in health and disease. Lancet Respir Med. 2019;7(4):358–364. doi:10.1016/S2213-2600(18)30529-0
   PubMed Web of Science ®Google Scholar
• Marott JL, Ingebrigtsen TS, Colak Y, Vestbo J, Lange P. Lung function trajectories leading to chronic obstructive pulmonary disease as predictors of exacerbations and mortality. Am J Respir Crit Care Med. 2020;202(2):210–218. doi:10.1164/rccm.201911-2115OC
   PubMed Web of Science ®Google Scholar
• Gershon AS, Warner L, Cascagnette P, Victor JC, To T. Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study. Lancet. 2011;378(9795):991–996. doi:10.1016/S0140-6736(11)60990-2
   PubMed Web of Science ®Google Scholar
• Jakobsen M, Anker N, Dollerup J, Poulsen PB, Lange P. Study on drug costs associated with COPD prescription medicine in Denmark. Clin Respir J. 2013;7(4):328–337. doi:10.1111/crj.12010
   PubMed Web of Science ®Google Scholar
• Postma DS, Bush A. Risk factors and early origins of chronic obstructive pulmonary disease. Lancet. 2015;385(9971):899–909. doi:10.1016/S0140-6736(14)60446-3
   PubMed Web of Science ®Google Scholar
• Vestbo J, Lange P. Natural history of COPD: focusing on change in FEV1. Respirology. 2016;21(1):34–43. doi:10.1111/resp.12589
   PubMed Web of Science ®Google Scholar
• Lange P, Ahmed E, Lahmar ZM, Martinez FJ, Bourdin A. Natural history and mechanisms of COPD. Respirology. 2021;26(4):298–321. doi:10.1111/resp.14007
   PubMed Web of Science ®Google Scholar
• Diab N, Gershon AS, Sin DD, et al. Underdiagnosis and overdiagnosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;198(9):1130–1139. doi:10.1164/rccm.201804-0621CI
   PubMed Web of Science ®Google Scholar
• Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med. 1968;278(25):1355–1360. doi:10.1056/NEJM196806202782501
   PubMed Web of Science ®Google Scholar
• Bignon J, Khoury F, Even P, Andre J, Brouet G. Morphometric study in chronic obstructive bronchopulmonary disease. Pathologic, clinical, and physiologic correlations. Am Rev Respir Dis. 1969;99(5):669–695. doi:10.1164/arrd.1969.99.5.669
   PubMed Web of Science ®Google Scholar
• Higham A, Quinn AM, Cancado JED, Singh D. The pathology of small airways disease in COPD: historical aspects and future directions. Respir Res. 2019;20(1):49. doi:10.1186/s12931-019-1017-y
   PubMed Web of Science ®Google Scholar
• Martinez FJ, Han MK, Allinson JP, et al. At the root: defining and halting progression of early chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;197(12):1540–1551. doi:10.1152/jappl.1967.22.1.95
   PubMed Web of Science ®Google Scholar
• Han MK, Steenrod AW, Bacci ED, et al. Identifying patients with undiagnosed COPD in primary care settings: insight from screening tools and epidemiologic studies. Chronic Obstr Pulm Dis. 2015;2(2):103–121. doi:10.15326/jcopdf.2.2.2014.0152
   PubMed Web of Science ®Google Scholar
• Lange P, Colak Y, Ingebrigtsen TS, Vestbo J, Marott JL. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis. Lancet Respir Med. 2016;4(6):454–462. doi:10.1016/S2213-2600(16)00098-9
   PubMed Web of Science ®Google Scholar
• Santus P, Radovanovic D, Henchi S, et al. Assessment of acute bronchodilator effects from specific airway resistance changes in stable COPD patients. Respir Physiol Neurobiol. 2014;197:36–45. doi:10.1016/j.resp.2014.03.012
   PubMed Web of Science ®Google Scholar
• Topalovic M, Derom E, Osadnik CR, et al. Airways resistance and specific conductance for the diagnosis of obstructive airways diseases. Respir Res. 2015;16:88. doi:10.1186/s12931-015-0252-0
   PubMed Web of Science ®Google Scholar
• Jarenback L, Eriksson G, Peterson S, Ankerst J, Bjermer L, Tufvesson E. Bronchodilator response of advanced lung function parameters depending on COPD severity. Int J Chron Obstruct Pulmon Dis. 2016;11:2939–2950. doi:10.2147/COPD.S111573
   PubMed Web of Science ®Google Scholar
• Topalovic M, Exadaktylos V, Troosters T, Celis G, Aerts JM, Janssens W. Non-linear parameters of specific resistance loops to characterise obstructive airways diseases. Respir Res. 2017;18(1):9. doi:10.1186/s12931-016-0484-7
   PubMed Web of Science ®Google Scholar
• Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(26):2645–2653. doi:10.1056/NEJMoa032158
   PubMed Web of Science ®Google Scholar
• McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011;365(17):1567–1575. doi:10.1056/NEJMoa1106955
   PubMed Web of Science ®Google Scholar
• Koo HK, Vasilescu DM, Booth S, et al. Small airways disease in mild and moderate chronic obstructive pulmonary disease: a cross-sectional study. Lancet Respir Med. 2018;6(8):591–602. doi:10.1016/S2213-2600(18)30196-6
   PubMed Web of Science ®Google Scholar
• Labaki WW, Gu T, Murray S, et al. Voxel-wise longitudinal parametric response mapping analysis of chest computed tomography in smokers. Acad Radiol. 2019;26(2):217–223. doi:10.1016/j.acra.2018.05.024
   PubMed Web of Science ®Google Scholar
• Sorkness RL, Bleecker ER, Busse WW, et al. Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. J Appl Physiol. 2008;104(2):394–403. doi:10.1152/japplphysiol.00329.2007
   PubMed Web of Science ®Google Scholar
• Mahut B, Caumont-Prim A, Plantier L, et al. Relationships between respiratory and airway resistances and activity-related dyspnea in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2012;7:165–171. doi:10.2147/COPD.S29745
   PubMed Web of Science ®Google Scholar
• Crisafulli E, Pisi R, Aiello M, et al. Prevalence of small-airway dysfunction among COPD patients with different GOLD stages and its role in the impact of disease. Respiration. 2017;93(1):32–41. doi:10.1159/000452479
   PubMed Web of Science ®Google Scholar
• Li K, Gao Y, Pan Z, et al. Influence of emphysema and air trapping heterogeneity on pulmonary function in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2019;14:2863–2872. doi:10.2147/COPD.S221684
   PubMed Web of Science ®Google Scholar
• Li Y, Li XY, Yuan LR, Wang HL, Pang M. Evaluation of small airway function and its application in patients with chronic obstructive pulmonary disease (Review). Exp Ther Med. 2021;22(6):1386. doi:10.3892/etm.2021.10822
   PubMed Web of Science ®Google Scholar
• Gibson GJ. Pulmonary hyperinflation a clinical overview. Eur Respir J. 1996;9(12):2640–2649. doi:10.1183/09031936.96.09122640
   PubMed Web of Science ®Google Scholar
• Gagnon P, Guenette JA, Langer D, et al. Pathogenesis of hyperinflation in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2014;9:187–201. doi:10.2147/COPD.S38934
   PubMed Web of Science ®Google Scholar
• Rossi A, Aisanov Z, Avdeev S, et al. Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD. Respir Med. 2015;109(7):785–802. doi:10.1016/j.rmed.2015.03.010
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Bertley JC, Chau LK, Webb KA. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med. 1997;155(1):109–115. doi:10.1164/ajrccm.155.1.9001298
   PubMed Web of Science ®Google Scholar
• Calverley PM, Koulouris NG. Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology. Eur Respir J. 2005;25(1):186–199. doi:10.1183/09031936.04.00113204
   PubMed Web of Science ®Google Scholar
• Puente-Maestu L, Stringer WW. Hyperinflation and its management in COPD. Int J Chron Obstruct Pulmon Dis. 2006;1(4):381–400. doi:10.2147/copd.2006.1.4.381
   PubMedGoogle Scholar
• Santus P, Radovanovic D, Di Marco F, Raccanelli R, Valenti V, Centanni S. Faster reduction in hyperinflation and improvement in lung ventilation inhomogeneity promoted by Aclidinium compared to glycopyrronium in severe stable COPD patients. A randomized crossover study. Pulm Pharmacol Ther. 2015;35:42–49. doi:10.1016/j.pupt.2015.11.001
   PubMed Web of Science ®Google Scholar
• Park J, Lee CH, Lee YJ, et al. Longitudinal changes in lung hyperinflation in COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:501–508. doi:10.2147/COPD.S122909
   PubMed Web of Science ®Google Scholar
• Poor HD, Kawut SM, Liu CY, et al. Pulmonary hyperinflation due to gas trapping and pulmonary artery size: the Mesa COPD Study. PLoS One. 2017;12(5):e0176812. doi:10.1371/journal.pone.0176812
   PubMed Web of Science ®Google Scholar
• Aurora P, Bush A, Gustafsson P, et al. Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis. Am J Respir Crit Care Med. 2005;171(3):249–256. doi:10.1164/rccm.200407-895OC
   PubMed Web of Science ®Google Scholar
• Lowe L, Murray CS, Custovic A, Simpson BM, Kissen PM, Woodcock A. Specific airway resistance in 3-year-old children: a prospective cohort study. Lancet. 2002;359(9321):1904–1908. doi:10.1016/S0140-6736(02)08781-0
   PubMed Web of Science ®Google Scholar
• Subbarao P, Hulskamp G, Stocks J. Limitations of electronic compensation for measuring plethysmographic airway resistance in infants. Pediatr Pulmonol. 2005;40(1):45–52. doi:10.1002/ppul.20217
   PubMed Web of Science ®Google Scholar
• Matthys H, Keller R, Herzog H. Plethysmographic assessment of trapped air in man. Respiration. 1970;27(5):447–461. doi:10.1159/000192700
   PubMed Web of Science ®Google Scholar
• Calverley PM, Burge PS, Spencer S, Anderson JA, Jones PW. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax. 2003;58(8):659–664. doi:10.1136/thorax.58.8.659
   PubMed Web of Science ®Google Scholar
• Bisgaard H, Nielsen KG. Plethysmographic measurements of specific airway resistance in young children. Chest. 2005;128(1):355–362. doi:10.1378/chest.128.1.355
   PubMed Web of Science ®Google Scholar
• Kaminsky DA. What does airway resistance tell us about lung function? Respir Care. 2012;57(1):85–96;discussion 96–9. doi:10.4187/respcare.01411
   Web of Science ®Google Scholar
• Eltayara L, Becklake MR, Volta CA, Milic-Emili J. Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;154(6 Pt 1):1726–1734. doi:10.1164/ajrccm.154.6.8970362
   PubMed Web of Science ®Google Scholar
• Ni Y, Yu Y, Dai R, Shi G. Diffusing capacity in chronic obstructive pulmonary disease assessment: a meta-analysis. Chron Respir Dis. 2021;18:14799731211056340. doi:10.1177/14799731211056340
   Web of Science ®Google Scholar
• Yanagisawa S, Ichinose M. Definition and diagnosis of asthma-COPD overlap (ACO). Allergol Int. 2018;67(2):172–178. doi:10.1016/j.alit.2018.01.002
   PubMed Web of Science ®Google Scholar
• Perez de Llano L, BG Cosio, Miravitlles M, Plaza V; group Cs. Accuracy of a new algorithm to identify asthma-COPD overlap (ACO) patients in a cohort of patients with chronic obstructive airway disease. Arch Bronconeumol. 2018;54(4):198–204. doi:10.1016/j.arbres.2017.10.007
   PubMed Web of Science ®Google Scholar
• Balasubramanian A, Kolb TM, Damico RL, Hassoun PM, McCormack MC, Mathai SC. Diffusing capacity is an independent predictor of outcomes in pulmonary hypertension associated with COPD. Chest. 2020;158(2):722–734. doi:10.1016/j.chest.2020.02.047
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Parker CM. COPD exacerbations. 3: pathophysiology. Review. Thorax. 2006;61(4):354–361. doi:10.1136/thx.2005.041830
   PubMed Web of Science ®Google Scholar
• Miravitlles M. Asthma-COPD Overlap (ACO) PRO-CON Debate. ACO: call Me by My Name. Copd. 2020;17(5):471–473. doi:10.1080/15412555.2020.1817883
   PubMedGoogle Scholar
• Papi A. Asthma COPD overlap PRO-CON debate. ACO: the mistaken term. Copd. 2020;17(5):474–476. doi:10.1080/15412555.2020.1817882
   PubMedGoogle Scholar